SCHEMBL6987612

SCHEMBL6987612

[CH2]c1ccc(OCc2ccccc2)cc1OC

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 6/20 0.58
ALOX5 P09917 1/20 0.53
PDGFRB P09619 1/20 0.50
PDGFRA P16234 1/20 0.50
MAPT P10636 4/20 0.48
ALDH1A1 P00352 2/20 0.48
ALOX12 P18054 2/20 0.48
GAA P10253 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
LMNA P02545 2/20 0.48
CYP1A2 P05177 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
CYP2C19 P33261 1/20 0.47
PTGS2 P35354 1/20 0.47
SLC6A3 Q01959 1/20 0.47
HIF1A Q16665 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL96800 0.88 ALOX5 (0.58) MAOBALOX5MAPTGAASMN1; SMN2
SCHEMBL5728865 0.87 MAOB (0.58) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL2090976 0.83 MAOB (0.62) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL18623122 0.83 MAOB (0.62) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL28085577 0.83 MAOB (0.46) MAOBALOX5MAPTL3MBTL1LMNA
SCHEMBL7852080 0.83 PARP10 (0.53) ALDH1A1GAAL3MBTL1BCHE
SCHEMBL8280802 0.82 MAOB (0.60) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL12473744 0.81 MAOB (0.58) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL6119729 0.81 MAOB (0.58) MAOBALOX5PDGFRBPDGFRAMAPT
SCHEMBL21327259 0.81 MAOB (0.58) MAOBALOX5PDGFRBPDGFRAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093157-A1 PIPERIDINE, PYRROLIDINE AND 2-OXO-1,3-OXAZINANE DERIVATIVES AS INHIBITORS OF BACTERIAL EFFLUX-PUMPS FOR THE TREATMENT OF MICROBIAL INFECTIONS BASILEA PHARMACEUTICA AG (CH) 2017-06-08 WO claimed
EP-1322617-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2003-07-02 EP disclosed
WO-2002024653-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2002-03-28 WO disclosed
EP-1163225-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2001-12-19 EP disclosed
US-6140325-A HAS ENDOTHELIN ANTAGONISTIC ACTION; FOR TREATING LIVER HYPOFUNCTION, ACUTE RENAL INSUFFICIENCY, CARDIAC INFARCTION OR LIVER INSUFFICIENCY, VASOCONSTRICTION TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-10-31 US disclosed
WO-2000055137-A1 COMPOUNDS AND METHODS FOR MODULATION OF ESTROGEN RECEPTORS SIGNAL PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed
CN-1106663-A Thienopyrimidine derivatives, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1995-08-16 CN disclosed